Will the future of human enhancement include the ability to naturally modify the state of human tissues and organs in order to cure degenerative diseases and affect complex regeneration?

We discuss this controversial field with Ira Pastor, the CEO of Bioqark, a biotech company that develops combinatorial biologics that aim to reverse underlying disease, degeneration, and the aging process.